MCE - Delayed Quote EUR

Atrys Health, S.A. (ATRY.MC)

Compare
3.3100 -0.0500 (-1.49%)
At close: 5:35 PM GMT+2
Currency in EUR All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
201,569.0000
201,569.0000
158,366.0000
121,014.0000
31,396.0000
--
Cost of Revenue
59,799.0000
59,799.0000
32,366.0000
20,121.0000
7,146.0000
--
Gross Profit
141,770.0000
141,770.0000
126,000.0000
100,893.0000
24,250.0000
--
Operating Expense
136,275.0000
136,275.0000
129,572.0000
113,285.0000
26,387.0000
--
Operating Income
5,495.0000
5,495.0000
-3,572.0000
-12,392.0000
-2,137.0000
--
Net Non Operating Interest Income Expense
-32,420.0000
-32,420.0000
-14,230.0000
-9,186.0000
-2,136.0000
--
Pretax Income
-33,696.0000
-33,696.0000
-26,794.0000
-24,882.0000
-5,381.0000
--
Tax Provision
-2,941.0000
-2,941.0000
-839.0000
-1,685.0000
167.0000
--
Net Income Common Stockholders
-45,590.0000
-45,590.0000
-23,147.0000
-23,255.0000
-5,548.0000
--
Diluted NI Available to Com Stockholders
-45,590.0000
-45,590.0000
-23,147.0000
-23,255.0000
-5,548.0000
--
Basic EPS
-0.60
--
-0.34
-0.46
-0.20
-0.01
Diluted EPS
-0.60
--
-0.34
-0.46
-0.20
-0.01
Basic Average Shares
75,810.5640
--
68,203.8100
50,282.9420
28,315.6180
21,463.0130
Diluted Average Shares
77,264.5080
--
70,471.9600
53,519.5280
30,938.9540
22,856.4260
Total Operating Income as Reported
-1,844.0000
-1,844.0000
-13,368.0000
-15,014.0000
-230.0000
--
Rent Expense Supplemental
1,055.0000
1,055.0000
877.0000
997.0000
24.0000
--
Total Expenses
196,074.0000
196,074.0000
161,938.0000
133,406.0000
33,533.0000
--
Net Income from Continuing & Discontinued Operation
-45,590.0000
-45,590.0000
-23,147.0000
-23,255.0000
-5,548.0000
--
Normalized Income
-26,572.5925
-26,572.5925
-18,227.4544
-21,804.0535
-5,419.0000
--
Interest Income
627.0000
627.0000
304.0000
1,848.0000
210.0000
--
Interest Expense
33,047.0000
33,047.0000
14,534.0000
5,757.0000
2,346.0000
--
Net Interest Income
-32,420.0000
-32,420.0000
-14,230.0000
-9,186.0000
-2,136.0000
--
EBIT
-649.0000
-649.0000
-12,260.0000
-19,125.0000
-3,035.0000
--
EBITDA
29,024.0000
29,024.0000
13,714.0000
1,663.0000
2,938.0000
--
Reconciled Cost of Revenue
59,799.0000
59,799.0000
32,366.0000
20,121.0000
7,146.0000
--
Reconciled Depreciation
29,673.0000
29,673.0000
25,974.0000
20,788.0000
5,973.0000
--
Net Income from Continuing Operation Net Minority Interest
-30,448.0000
-30,448.0000
-25,697.0000
-23,209.0000
-5,548.0000
--
Total Unusual Items Excluding Goodwill
-4,246.0000
-4,246.0000
-7,711.0000
-1,507.0000
-172.0000
--
Total Unusual Items
-4,246.0000
-4,246.0000
-7,711.0000
-1,507.0000
-172.0000
--
Normalized EBITDA
33,270.0000
33,270.0000
21,425.0000
3,170.0000
3,110.0000
--
Tax Rate for Calcs
0.0001
0.0001
0.0000
0.0001
0.0003
--
Tax Effect of Unusual Items
-370.5925
-370.5925
-241.4544
-102.0535
-43.0000
--
12/31/2019 - 7/22/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers